These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19060535

  • 1. Out with the old, in with the new: immunosuppression minimization in children.
    Sarwal MM.
    Curr Opin Organ Transplant; 2008 Oct; 13(5):513-21. PubMed ID: 19060535
    [Abstract] [Full Text] [Related]

  • 2. Long-term maintenance therapy with calcineurin inhibitors: an update.
    Campistol JM.
    Transplant Proc; 2010 Nov; 42(9 Suppl):S21-4. PubMed ID: 21095445
    [Abstract] [Full Text] [Related]

  • 3. Evidence for immunosuppression in lung transplantation.
    Hopkins PM, McNeil K.
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [Abstract] [Full Text] [Related]

  • 4. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 5. Can the early elimination of calcineurin inhibitors result in clinical benefits?
    Weir MR.
    Transplant Proc; 2010 Nov 15; 42(9 Suppl):S16-20. PubMed ID: 21095444
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years.
    Engelen MA, Amler S, Welp H, Vahlhaus C, Gunia S, Sindermann JR, Rothenburger M, Stypmann J.
    Transplantation; 2011 May 27; 91(10):1159-65. PubMed ID: 21478817
    [Abstract] [Full Text] [Related]

  • 7. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study.
    Ponticelli C, Salvadori M, Scolari MP, Citterio F, Rigotti P, Veneziano A, Bartezaghi M, EVEREST Study.
    Transplantation; 2011 May 27; 91(10):e72-3. PubMed ID: 21540717
    [No Abstract] [Full Text] [Related]

  • 8. Steroid avoidance or withdrawal in kidney transplantation.
    Pascual J.
    Curr Opin Organ Transplant; 2011 Dec 27; 16(6):600-5. PubMed ID: 21971514
    [Abstract] [Full Text] [Related]

  • 9. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 10. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK, Weir MR.
    Curr Opin Organ Transplant; 2008 Dec 27; 13(6):614-21. PubMed ID: 19060552
    [Abstract] [Full Text] [Related]

  • 11. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW, Chudzinski R.
    Transplantation; 2009 Jan 27; 87(2):164-5. PubMed ID: 19155968
    [No Abstract] [Full Text] [Related]

  • 12. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
    Danger R, Giral M, Soulillou JP, Brouard S.
    Curr Opin Organ Transplant; 2008 Dec 27; 13(6):609-13. PubMed ID: 19060551
    [Abstract] [Full Text] [Related]

  • 13. Advances in immunosuppression for pancreas transplantation.
    Singh RP, Stratta RJ.
    Curr Opin Organ Transplant; 2008 Feb 27; 13(1):79-84. PubMed ID: 18660711
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CNIs: immediate benefits but storing problems for the future?
    Kiuchi T.
    Transplantation; 2008 Oct 27; 86(8):1026-7. PubMed ID: 18946338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunological risks of minimization strategies.
    Snanoudj R, Tinel C, Legendre C.
    Transpl Int; 2015 Aug 27; 28(8):901-10. PubMed ID: 25809144
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitors in liver transplantation: to be or not to be.
    Castroagudín JF, Molina E, Varo E.
    Transplant Proc; 2011 Aug 27; 43(6):2220-3. PubMed ID: 21839238
    [Abstract] [Full Text] [Related]

  • 19. Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.
    Conti DJ, Petrov R, Elbalhoul O, Gallichio M.
    Transpl Immunol; 2008 Nov 27; 20(1-2):12-3. PubMed ID: 18793727
    [Abstract] [Full Text] [Related]

  • 20. Is there such a thing as protocol immunosuppression in liver transplantation?
    McCaughan GW, Sze KC, Strasser SI.
    Expert Rev Gastroenterol Hepatol; 2015 Jan 27; 9(1):1-4. PubMed ID: 25164689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.